Newron Pharmaceuticals S.p.A. (SWX:NWRN)
Switzerland · Delayed Price · Currency is CHF 16.40
0.00 (0.00%)
Apr 22, 2026, 5:30 PM CET
Newron Pharmaceuticals Market Cap
Newron Pharmaceuticals has a market cap or net worth of 341.22 million as of April 22, 2026. Its market cap has increased by 126.44% in one year.
Market Cap
341.22M
Enterprise Value
349.86M
Revenue
17.81M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.40
Market Cap Chart
Since December 12, 2006, Newron Pharmaceuticals's market cap has increased from 309.05M to 341.22M, an increase of 10.41%. That is a compound annual growth rate of 0.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 341.22M | -28.33% |
| Dec 30, 2025 | 476.07M | 173.36% |
| Dec 30, 2024 | 174.16M | 97.16% |
| Dec 29, 2023 | 88.33M | 219.35% |
| Dec 30, 2022 | 27.66M | -4.32% |
| Dec 30, 2021 | 28.91M | -24.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Idorsia | 936.11M |
| Basilea Pharmaceutica AG | 689.56M |
| Santhera Pharmaceuticals Holding AG | 245.39M |
| BioVersys AG | 164.33M |
| Molecular Partners AG | 130.94M |
| Xlife Sciences AG | 129.77M |
| EvoNext Holdings | 6.16M |
| Addex Therapeutics | 5.13M |